Archive for the ‘Books’ Category
Product Description
For the first time in history, permanent weight loss can be achieved through a remarkable program that ends food victimization through the use of medication. In Thinner at Last, Steven Lamm, M.D., explains how two medications (fenfluramine and phentermine) taken together actually enhance the body’s natural inclination to be thin and healthy. In this book, you will also learn how to:
– Determine whether you are a candidate for the medications
– Locate a knowledgeable, sympathetic physician
– Distinguish fact from fiction concerning the benefits and risk of Redux (dexfenfluramine)
– Liberate yourself from yo-yo dieting and food obsessions
– Calculate how much weight you can expect to lose — and how quickly
Already proven to be much more effective than traditional diet programs, this plan has helped countless Americans realize their dreams of being thinner at last — not for a month or a year, but for a lifetime.
Product Description
After Florida led the way in banning the Phen-Fen weight-loss plan, millions of people began searching for a safe, effective alternative. They’ll find it here, in Harvard-trained M.D. Michael Anchors’ innovative program that’s been touted on national radio and television.Amazon.com Review
Phentermine has been used safely as a weight-loss drug for more than 30 years in the U.S., but when combined with fenfluramine, it produces side effects quite threatening to the heart and lungs. This latest finding has unleashed yet another pharmaceutical controversy. But Phen-Fen has proven so effective in weight loss that many patients won’t stop taking it. Safer Than Phen-Fen!, offering the only weight loss program as effective as Phen-Fen but without the side effects, should thrill these sufferers.
Harvard-trained in biochemistry and an expert on obesity treatment, Dr. Michael Anchors has created a new and safe combination: phentermine and Prozac. Prozac, a serotine reuptake inhibitor, controls appetite. The dosage used in weight control is less than that used to treat depression. Anchors claims that obesity is a genetic, biochemical brain disorder. Discussions on the nature and causes of obesity (as well as the related health risks), how diets contribute to permanent weight gain, and a diet and exercise plan in conjunction with medical therapy all reflect his claim that with new understanding comes more enlightened treatments. A chapter addressed to physicians is consistent with Anchors’s belief that knowledge is power; patients can discuss the treatment put forth in Safer Than Phen-Fen! with their doctors.
Product Description
This digital document is an article from Family Practice News, published by International Medical News Group on August 1, 2003. The length of the article is 1167 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.
Citation Details
Title: Take charge of treating obese adolescents: stay up to date.(Children’s Health)
Author: Timothy F. Kirn
Publication: Family Practice News (Magazine/Journal)
Date: August 1, 2003
Publisher: International Medical News Group
Volume: 33 Issue: 15 Page: 53(1)
Distributed by Thomson Gale
Take charge of treating obese adolescents: stay up to date.: An article from: Family Practice News
Product Description
This digital document is an article from Family Practice News, published by International Medical News Group on March 1, 2000. The length of the article is 496 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.
Citation Details
Title: Side Effects Limit Effectiveness Of Drug Treatment of Obesity.(Brief Article)(Statistical Data Included)
Author: Doug Brunk
Publication: Family Practice News (Magazine/Journal)
Date: March 1, 2000
Publisher: International Medical News Group
Volume: 30 Issue: 5 Page: 25
Article Type: Brief Article, Statistical Data Included
Distributed by Thomson Gale
A primer on fen-phen litigation: allegations and defenses.: An article from: Defense Counsel Journal
Product Description
This digital document is an article from Defense Counsel Journal, published by International Association of Defense Counsels on July 1, 1998. The length of the article is 4690 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.
Citation Details
Title: A primer on fen-phen litigation: allegations and defenses.
Author: John T. Evans
Publication: Defense Counsel Journal (Refereed)
Date: July 1, 1998
Publisher: International Association of Defense Counsels
Volume: 65 Issue: 3 Page: 353
Distributed by Thomson Gale
A primer on fen-phen litigation: allegations and defenses.: An article from: Defense Counsel Journal
Product Description
This digital document is an article from Trial, published by Association of Trial Lawyers of America on January 1, 1998. The length of the article is 3102 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.
From the supplier: How fen-phen and Redux came to be used by approximately 6 mil Americans reflects dangerous practices among the manufacturing, medical and weight loss industries. Both had FDA approval as short-term die aids, but were never supposed to be used together as a diet-drug concoction. Demand for Fen-phen surged in 1992 after one article in an obscure medical journal. In 1995, the FDA was asked to approve Redux, and there were concerns about the drug’s safety because of reports of primary pulmonary hypertension which had been linked to its use, and heart valve damage was also a possibility. After a Mayo Clinic report in July 1997, both drugs were recalled.
Citation Details
Title: Fen-phen and Redux: a tale of three drugs.
Author: Paul D. Rheingold
Publication: Trial (Magazine/Journal)
Date: January 1, 1998
Publisher: Association of Trial Lawyers of America
Volume: 34 Issue: n1 Page: 78(5)
Distributed by Thomson Gale
Fen-phen and Redux: a tale of three drugs.: An article from: Trial
Product Description
This digital document is an article from Family Practice News, published by International Medical News Group on February 15, 2004. The length of the article is 836 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.
Citation Details
Title: Phentermine + Prozac may offer safe obesity Tx: data from one study.(Rx)
Author: Patrice G.W. Norton
Publication: Family Practice News (Magazine/Journal)
Date: February 15, 2004
Publisher: International Medical News Group
Volume: 34 Issue: 4 Page: 81(1)
Distributed by Thomson Gale